International Women’s Day, Nanoparticles and Delivery, Novo Nordisk’s Expansion, and Organoids for Congenital Conditions

Episode 12 (March 8, 2024): Featuring Julianna LeMieux (Deputy Editor-in-Chief, GEN), Uduak Thomas (Senior Editor, GEN), and Alex Philippidis (Senior Business Editor, GEN), moderated by Fay Lin (Senior Editor, GEN Biotechnology)

This week, the GEN editors cover a recent interview with the Lost Women of Science, advances in delivery with lipid nanoparticles, Novo Nordisk’s expansion in the Boston area, and how organoids derived from amniotic fluid show promise for understanding fetal diseases.

Listed below are key references to the GEN stories, media, and other items discussed in this episode of Touching Base:

Lost Women of Science Receive Overdue Recognition, Inspire Present-Day Scientists 
By Julianna LeMieux, PhD, GEN, March 7, 2024.

Women in the C-Suite Discuss the Importance of Representation in Leadership
By GEN, March 7, 2024.

Lipid Nanoparticles Engineered to Target Lung Cells Reduce Tumor Size in Mice
By GEN, March 4, 2024.

Novel Thio-lipids Developed Capable of Reaching Eyes and Lungs in Animals
By GEN, March 5, 2024.

Novo Nordisk Expands Boston Area Research and Early Development
By Alex Philippidis, GEN, March 2, 2024.

Metal-Organic Nanoparticles Enable Better Vaccine Delivery, Stronger Immune Response
By GEN, March 6, 2024.

Organoids Originating from Cells in Amniotic Fluid Could Illiminate Congential Conditions
By GEN, March 5, 2024.